. Author manuscript; available in PMC: 2015 Jan 1.

Published in final edited form as: Respir Med. 2013 Nov 13;108(1):162–170. doi: 10.1016/j.rmed.2013.11.002

Table 5.

Predictive Biomarkers and Univariable Logistic Regression Predicting CRS with Polyps

Predictor	CRS without polyps^* N=52	CRS with polyps^* N=11	Crude OR (95%CI)^†	P-value
Eotaxin (log₁₀ pg/mL)	125 (93–172)	79 (65–432)	0.04 (0.00–1.49)	0.082
IFN-γ (log₁₀ pg/mL)	8.1 (4.8–20.1)	7.6 (3.3–9.3)	0.15 (0.02–1.32)	0.087
IL-4 (log₁₀ pg/mL)	3.2 (0.5–9.1)	0.5 (0.1–2.2)	0.52 (0.26–1.03)	0.062
IL-13 (log₁₀ pg/mL)	3.0 (0.5–18.7)	1.4 (0.5–6.9)	0.51 (0.21–1.27)	0.148
VEGF (log₁₀ pg/mL)	144 (88–247)	64 (48–94)	0.08 (0.01–0.70)	0.022
PMN count, ×10³	3.6 (2.9–4.2)	2.9 (2.5–3.4)	0.41 (0.18–0.94)	0.036
Eosinophil count, ×10	16 (11–23)	25 (18–43)	1.04 (1–1.09)	0.058

Definition of abbreviations: OR = odds ratio; IFN-γ = interferon-gamma; IL-4 = interleukin-4; IL-13 = interleukin-13;VEGF = vascular endothelial growth factor; PMN = polymorphonuclear neutrophils; 95%CI = 95% confidence interval.

Values Expressed as Median (IQR).